eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Bristol-Myers Squibb Pharmaceutical Limited
Bristol-Myers Squibb House, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex, UB8 1DH , UK
Telephone: +44 (0)1895 523 000
Fax: +44 (0)1895 523 010
Medical Information Direct Line: +44 (0)1895 523 740
Medical Information e-mail: medical.information@bms.com
Medical Information Fax: +44 (0)1895 523 677

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 31/01/2012
PIL Sprycel 20mg, 50mg, 70mg, 80mg, 100mg and 140mg Film-Coated Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 31/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 11/10/2011 and displayed until 31/01/2012
Reasons for adding or updating:
  • Change to date of revision
Updated on 23/12/2010 and displayed until 11/10/2011
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 17/12/2010 and displayed until 23/12/2010
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to side-effects
  • Introduction of new strength
  • Introduction of new pack/pack size
Updated on 26/05/2010 and displayed until 17/12/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 19/03/2009 and displayed until 26/05/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
  • Change to dosage and administration
Updated on 22/01/2009 and displayed until 19/03/2009
Reasons for adding or updating:
  • Introduction of new strength
Updated on 01/08/2008 and displayed until 22/01/2009
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 24/09/2007 and displayed until 01/08/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to, or new, use for medicine
  • Change to date of revision
Updated on 28/02/2007 and displayed until 24/09/2007
Reasons for adding or updating:
  • Extra statutory information
Updated on 01/12/2006 and displayed until 28/02/2007
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  dasatinib monohydrate